Het Medisch Centrum Leeuwarden is een ziekenhuis in Leeuwarden. Het MCL ligt in het zuiden van Leeuwarden en heeft 653 bedden. Het is een van de grootste ziekenhuizen van Nederland. Het MCL heeft een regionale functie voor de provincie Friesland.

During the past decade, Medisch Centrum Leeuwarden conducted 131 clinical trials. In the 10-year time frame, 131 clinical trials started and 29 clinical trials were completed, i.e. on average, 22.1% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 19 clinical trials were completed. i.e. 28.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medisch Centrum Leeuwarden" #1 sponsor was "Medical Centre Leeuwarden" with 25 trials, followed by "The Netherlands Cancer Institute" with 11 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 10 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 9 trials sponsored and "University Medical Center Groningen" with 9 trials sponsored. Other sponsors include 128 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medisch Centrum Leeuwarden" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 10 trials as a collaborator, "Borstkanker Onderzoek Groep" with 7 trials as a collaborator, "Dutch Cancer Society" with 6 trials as a collaborator, "Erasmus Medical Center" with 5 trials as a collaborator and "Leiden University Medical Center" with 5 trials as a collaborator. Other collaborators include 208 different institutions and companies that were collaborators in the rest 174 trials.

According to Clinical.Site data, the most researched conditions in "Medisch Centrum Leeuwarden" are "Coronary Artery Disease" (14 trials), "Breast Cancer" (8 trials), "Atrial Fibrillation" (5 trials), "Aortic Valve Stenosis" (4 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Medisch Centrum Leeuwarden" in a lesser frequency.

Most popular intervention types in "Medisch Centrum Leeuwarden" are "Drug" (96 trials), "Device" (34 trials), "Other" (31 trials), "Procedure" (25 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Rituximab" (5 trials), "Bevacizumab" (4 trials), "Dexamethasone" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Medisch Centrum Leeuwarden" are 175 trials for "All" genders, 15 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 81 active trials in "Medisch Centrum Leeuwarden". 2 are not yet recruiting, 47 are recruiting, 28 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 81 completed trials in Medisch Centrum Leeuwarden, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Medisch Centrum Leeuwarden, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 46 trials that are defined as “Not Applicable".

Medisch Centrum Leeuwarden has several departments that took part in Clinical trials: "Medisch Centrum Leeuwarden; Reumatology" - 3 trials, "Medical Centre Leeuwarden - Intensive Care Unit" - 2 trials